医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
22期
101-101
,共1页
肿瘤标志物%肺癌检验%应用%诊断
腫瘤標誌物%肺癌檢驗%應用%診斷
종류표지물%폐암검험%응용%진단
Tumor markers%Lung cancer inspection%Application%Diagnosis
目的：探究肿瘤标志物在肺癌检验中的临床应用。方法分别检测50例健康体检者(正常对照组)、50例肺癌患者(肺癌组)、50例肺部良性病变患者(良性对照组)的CYFRA21-1、CEA、NSE肿瘤标志物，并用统计学方法进行比对分析。结果实验组的CYFRA21-1为25.76±12.06，CEA为28.13±12.42，NSE为44.72±21.04；良性对照组的CYFRA21-1为2.81±1.36，CEA为1.86±0.73，NSE为11.13±3.06；正常对照组的CYFRA21-1为2.46±0.96，CEA为2.06±0.79，NSE为10.76±2.09。由此可见，实验组患者的血清CYFRA21-1、CEA、NSE水平明显高于良性对照组以及正常对照组，差异显著，有统计学意义(P<0.05)。结论检测CYFRA21-1、CEA、NSE可有效提高肺癌诊断的准确度，对肺癌的诊断有一定的的临床应用价值，但通过CYFRA21-1、CEA、NSE检测判定患者的病情、疗效以及预后分析需做进一步研究。
目的：探究腫瘤標誌物在肺癌檢驗中的臨床應用。方法分彆檢測50例健康體檢者(正常對照組)、50例肺癌患者(肺癌組)、50例肺部良性病變患者(良性對照組)的CYFRA21-1、CEA、NSE腫瘤標誌物，併用統計學方法進行比對分析。結果實驗組的CYFRA21-1為25.76±12.06，CEA為28.13±12.42，NSE為44.72±21.04；良性對照組的CYFRA21-1為2.81±1.36，CEA為1.86±0.73，NSE為11.13±3.06；正常對照組的CYFRA21-1為2.46±0.96，CEA為2.06±0.79，NSE為10.76±2.09。由此可見，實驗組患者的血清CYFRA21-1、CEA、NSE水平明顯高于良性對照組以及正常對照組，差異顯著，有統計學意義(P<0.05)。結論檢測CYFRA21-1、CEA、NSE可有效提高肺癌診斷的準確度，對肺癌的診斷有一定的的臨床應用價值，但通過CYFRA21-1、CEA、NSE檢測判定患者的病情、療效以及預後分析需做進一步研究。
목적：탐구종류표지물재폐암검험중적림상응용。방법분별검측50례건강체검자(정상대조조)、50례폐암환자(폐암조)、50례폐부량성병변환자(량성대조조)적CYFRA21-1、CEA、NSE종류표지물，병용통계학방법진행비대분석。결과실험조적CYFRA21-1위25.76±12.06，CEA위28.13±12.42，NSE위44.72±21.04；량성대조조적CYFRA21-1위2.81±1.36，CEA위1.86±0.73，NSE위11.13±3.06；정상대조조적CYFRA21-1위2.46±0.96，CEA위2.06±0.79，NSE위10.76±2.09。유차가견，실험조환자적혈청CYFRA21-1、CEA、NSE수평명현고우량성대조조이급정상대조조，차이현저，유통계학의의(P<0.05)。결론검측CYFRA21-1、CEA、NSE가유효제고폐암진단적준학도，대폐암적진단유일정적적림상응용개치，단통과CYFRA21-1、CEA、NSE검측판정환자적병정、료효이급예후분석수주진일보연구。
Objective To explore the tumor markers in lung cancer clinical application of inspection.Methods Detected in 50 cases of healthy physical examination were normal (control group) and 50 cases of patients with lung cancer, lung cancer group) and 50 patients with lung benign lesions (benign group), CEA, NSE CYFRA21-1 tumor markers,And comparative analysis with the statistical methods. Results The experimental CYFRA21-1 was 25.76±12.06, CEA was 28.13±12.42, NSE was 44.72±21.04;Benign CYFRA21-1 was 2.81±1.36 in the control group, the CEA was 1.86±0.73, NSE was 11.13±3.06;Normal CYFRA21-1 was 2.46±0.96 in the control group, the CEA was 2.06±0.79, NSE was 10.76±2.09.Therefore, the experimental group patients' serum CYFRA21-1, CEA, NSE levels significantly higher than the positive control group and normal control group,Significant dif erence was statistical y significant ( <0.05).Conclusion Detection CYFRA21-1, CEA, NSE can ef ectively enhance the accuracy of diagnosis of lung cancer, the diagnosis of lung cancer has certain clinical application value,But through the CYFRA21-1, CEA, NSE detection to determine the patient's il ness, curative ef ect and prognosis analysis needs to be studied further.
